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ABSTRACT
Objective: Candidiasis is a common opportunistic infection of the oral cavity caused by a yeast-like fungus called Candida. Candida glabrata is the 
second most frequently isolated species from this condition, after Candida albicans. This study aimed to evaluate the effect of Nigella sativa (black 
cumin), known to possess antifungal properties, on the viability of C. glabrata.
Methods: C. glabrata was added to a 96-microwell plate that was coated with artificial saliva and exposed to various concentrations (6.25%, 12.5%, 
25%, and 50%) of N. sativa seed extract; amphotericin B (250 mg/mL) was used as the positive control and 200 µL of yeast nitrogen base medium as 
the negative control. The viability percentage of C. glabrata was determined by MTT assay.
Results: The results showed that the viability values of C. glabrata were lower after exposure to the N. sativa seed extract when compared with the 
negative control.
Conclusion: The viability of Candida glabrata was decreased with increasing concentrations of the extract.
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INTRODUCTION
Candidiasis is the most common opportunistic infection of the oral 
cavity and is caused by the yeast-like fungus Candida albicans [1]. Oral 
candidiasis is mostly found in the elderly and in patients with dentures 
and HIV-AIDS. It has been reported that more than 90% of individuals 
infected with HIV suffer from oral candidiasis [2].
C. albicans is the most commonly isolated pathogenic fungus in the oral 
cavity, but the number of isolated species other than C. albicans has also 
increased [2]. The incidence of isolated C. albicans in the oral cavity 
was reported to be 95% in individuals with HIV [3]. The other species 
that plays a role in oral infections in humans include Candida glabrata, 
Candida tropicalis, Candida dubliniensis, Candida pseudo tropicalis, 
Candida guilliermondii, Candida krusei, Candida lusitaniae, Candida 
parapsilosis, and Candida stellatoidea [2-4].
C. glabrata is the second most frequently isolated species in oral 
candidiasis after C. albicans [5]. Increased use of immunosuppressive 
agents in conjunction with broad-spectrum antimycotic therapy has 
resulted in a significant increase in mucosal and systemic infections 
caused by C. glabrata. A major constraint in C. glabrata infections 
is the increase in the number of C. glabrata due to their innate 
resistance mechanisms against antimycotic azole therapy to maintain 
viability [6,7]. Thus, biofilms formed by C. glabrata may be highly 
resistant to some antifungal medications [8]. It has been reported that 
6.8% of C. glabrata are resistant to fluconazole, 23.7% are resistant to 
itraconazole, and 2.5% are resistant to amphotericin B [9,10].
The most common side effects of amphotericin B and the azole 
antifungal group of medications are gastrointestinal symptoms, 
with hepatotoxicity being one of the most severe side effects [11,12]. 
Consequently, these antifungal agents are less effective for the 
treatment of oral candidiasis due to their side effects and also due to 
the resistance of Candida to these drugs, thus warranting the need for 
the development of better antifungal drugs against C. glabrata.
Medicinal plants serve as an alternative therapy, a safe option, and in 
some cases, the only effective mode of treatment [13]. One type of plant 
that has been under consideration among herbalists is Nigella sativa 
(black cumin) [14]. N. sativa seeds have been traditionally used for 
centuries in the Middle East, North Africa, and South Asia as a natural 
remedy for various diseases [15].
N. sativa seed extract has active antifungal properties. Several previous 
studies have been conducted to investigate the effects of these seeds 
as antifungals; the extracts of N. sativa seeds have been shown to 
inhibit the growth of several types of Candida fungi such as C. albicans, 
C. parapsilosis, and C. tropicalis [15-17]. However, the active nature of 
N. sativa seeds as an antifungal agent and the effect of the seed extract 
on the viability of C. glabrata is unknown. Hence, the present study 
aimed to evaluate the effect of N. sativa seed extract on the viability of 
C. glabrata.
METHODS
Premade yeast nitrogen base (YNB) medium (5 mL) was diluted with 
45 mL sterile Milli-Q in a 50 mL tube, ensuring that the pH was neutral 
(pH=7). Next, 10 mL of the diluted YNB was poured into a sterile 
reaction tube. A single colony of C. glabrata in Sabouraud Dextrose 
Agar medium was added to the test tube. The culture of C. glabrata in 
YNB medium was made in Duplo. After incubation of the culture for 
18 h on a shaker (150 rpm) at 37°C, the growth of C. glabrata in YNB 
medium was measured by determining the optical density (OD) value 
using a spectrophotometer. In a microwell plate, 200 µL of sterile single 
dilution YNB was added as a blank. The cultured C. glabrata (200 µL) 
was then added to the wells. This procedure was performed Duplo. 
The OD values were read at a wavelength of 490 nm. The C. glabrata 
suspension was subsequently diluted to 10−10.
After obtaining an OD of 0.514 and a colony-forming unit of 
13×1011/mL, 200 mL of the C. glabrata suspension was poured into 
a 96-microwell plate coated with saliva and incubated for 120 min at 
37°C. The microorganisms that remained unattached to the saliva were 
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removed following two rinses with 200 µL of PBS. Subsequently, 200 µL 
of N. sativa seed extracts of varying concentrations (6.25%, 12.5%, 
25%, and 50%) were added into each well. Amphotericin B (4 µL) and 
YNB (196 µL) were added to the wells as positive controls, whereas 
200 µL of YNB was taken as the negative control. This procedure was 
performed in 12 wells for each group. The 96-microwell plate was then 
incubated for 24 h at 37°C. Images of the morphology of C. glabrata 
were obtained. In addition, an MTT test was performed.
The OD values were obtained from the spectrophotometer at a 
wavelength of 490 nm, and the viability of C. glabrata was calculated 
using the following formula: The viability of S. sanguinis was calculated 
using the formula:
    
( ) Absorbance value of treatment groupCell viability % = ×100%
Absorbance value of control group
Statistical analysis
Data were processed statistically using. The Kolmogorov–Smirnov test 
was used to assess the distribution of data, and one-way analysis of 
variance followed by post hoc tests was used to determine the level of 
significance between groups. Pearson’s correlation was used to assess 
linear associations between the concentrations of the extract and the 
viability of the microorganisms. The level of significance was set at 
p<0.05.
RESULTS
The percentage of viability of C. glabrata was 18% in the positive 
control group (amphotericin B) and 100% in the negative control group 
(Fig. 1). In the treatment group, C. glabrata viability after exposure 
with 6.25% N. sativa seed extract was 50%, whereas exposure with 
12.5% seed extract resulted in viability of 47%. Exposure to 25% 
and 50% N. sativa seed extract demonstrated 24% and 35% viability 
of C. glabrata, respectively. Among the various concentrations of the 
N. sativa seed extract, the highest percentage of C. glabrata viability 
was found in the treatment group, which decreased with increasing 
concentrations of the extract, except for the 50% concentration.
The average OD values obtained from the spectrophotometer are shown 
in Fig. 2. The mean OD in the negative control group (0.773±0.050) was 
higher than that in the treatment groups with the various concentrations 
of the seed extract. The average ODs of the 6.25%, 12.5%, 25%, and 50% 
N. sativa seed extracts were 0.388±0.052, 0.367±0.114, 0.187±0.027, 
and 0.187±0.027, respectively.
The results of the Kolmogorov–Smirnov normality test revealed that 
the data had a normal distribution (p>0.05). Homogeneity variance 
was evaluated using the Levene test, which resulted in a value of 8753 
with 0.000 significance, thus accepting the null hypothesis of the 
current study that N. sativa seed extracts can decrease the viability of 
C. glabrata.
Statistically significant differences in average OD (p<0.05) were 
observed between the control group with the various treatment groups 
(6.25%, 12.5%, 25%, and 50%). Conversely, average OD in the 6.25% 
treatment group (0.388) was not significantly different from that in the 
12.5% group (0.367). Furthermore, no significant difference in average 
OD was noted between the group exposed to amphotericin B (0.143) 
and that exposed to 25% N. sativa seed extract (0.187).
The correlation coefficient between the OD of C. glabrata and the acting 
group was −0.592**, thus indicating a negative relationship between the 
ODs of C. glabrata and the treatment group. The viability of C. glabrata 
was found to decrease with the increase in the concentration of the 
N. sativa seed extract (p=0.000).
DISCUSSION
The present study aimed to evaluate the effect of various concentrations 
of N. sativa seed extract (6.25%, 12.5%, 25%, and 50%) on the viability 
of C. glabrata.
The percentage of viability of C. glabrata was calculated by comparing 
the mean OD values between the treatment groups and the negative 
control group. The 6.25%, 12.5%, 25%, and 50% concentrations of 
N. sativa seed extract decreased the viability of C. glabrata; the viability 
in the group exposed to the 6.25% N. sativa seed extract was lower than 
Fig. 1. Percentage of Candida glabrata viability after exposure to various concentrations of Nigella sativa seed extract for 24 h at 37°C
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that in the control group, indicating that exposure to low concentrations 
of the extract might decrease the viability of these microorganisms. 
Exposure to the 12.5% extract resulted in a slight decrease in C. glabrata 
viability when compared with the 6.25% extract, statistical significance 
notwithstanding.
The present study did not investigate the mechanism by which, 
N. sativa seed extract causes an increase or decrease in C. glabrata 
viability. In a previous study, phytochemical analysis of N. sativa seed 
ethanolic extracts had revealed the presence of two main components: 
Thymoquinone and nigellone; thymoquinone is thought to be involved 
in reducing the viability of C. glabrata [18].
The thymoquinone-mediated antifungal activity of N. sativa seeds was 
evaluated by Aljabre et al. and Akhtar et al., and it was found to effectively 
inhibit the growth of the dermatophytes Aspergillus niger (minimum 
inhibitory concentration, 2 mg/mL) and Fusarium solani [19,20]. 
Dermatophytes are a group of fungi that attack the stratum corneum 
of the skin, hair, and nails and can cause a type of infection called 
tinea or ringworm infection. Arthrospora is a morphological form of 
dermatophytes that play an important role in infection. Subsequently, 
the effect of thymoquinone on arthrospora dermatophytes was 
investigated by Aljabre et al. in 2009, wherein thymoquinone was 
reported to inhibit the germination of arthrospores [19]. On the basis 
of the results of their study, it may be assumed that the decrease in 
the viability of C. glabrata by N. sativa seed extract occurs due to the 
inhibition of the germination of blastoconidia through thymoquinone 
activity.
In addition to thymoquinone, the other components of the N. sativa 
seed extract suspected to have antifungal effects are thymol and 
carvacrol. In a previous study, thymol and carvacrol were reported 
to inhibit ergosterol synthesis in Candida [21]. Ergosterol is the 
main component of sterol found in the yeast cell membrane and is 
responsible for maintaining cell function. The viability of C. glabrata 
was decreased by N. sativa seed extract due to the inhibition of 
ergosterol synthesis by thymol and carvacrol, which occurs as a result 
of interactions with demetilase C14A, an enzyme that depends on P-450 
cytochrome required for the conversion of lanosterol to ergosterol [21]. 
Ergosterol deficiency causes membrane fluidity, resulting in increased 
permeability and growth restriction, and cell multiplication [12]. 
Inhibition of ergosterol synthesis may also lead to the disruption of 
nucleic acid synthesis or accumulation of peroxides in fungal cells that 
can cause damage [11].
The lowest percentage of C. glabrata viability was observed at a 
N. sativa seed extract concentration of 25%, which suggests that 
this concentration is optimum for use during treatment. In 50% 
concentration group, the viability of C. glabrata was increased, 
probably due to the ability of these microorganisms to tolerate 14α 
demetilase deficiency during ergosterol biosynthesis; thus, the higher 
concentrations of the extracts had exceeded the optimum dose [22]. 
The decrease in effectiveness after reaching the optimum dose has 
been explained using a hyperbolic curve, wherein the increase in drug 
concentration will lead to an increase in the effectiveness of the drug 
until it reaches its maximum point; however, the effectiveness of the 
drug decreases if the concentration of the drug is increased beyond the 
maximum point on the curve [23].
In another study where static N. sativa seed oil was used as a test 
material against C. albicans, C. glabrata, C. parapsilosis, and C. krusei, the 
best antifungal activity was found against C. glabrata (inhibition zone, 
12 mm) and C. parapsilosis (inhibition zone, 13.33 mm) [24].
Ethanol (96%) has been used as a solvent for the extraction of N. sativa 
seed oil and shown no antifungal effects, indicating that it does not 
affect the viability of C. glabrata [25]. In the current study, we did not 
use 96% ethanol in the negative controls.
The results of the present study indicated that an unsuitable MTT test 
was used to test the cytotoxic effect of N. sativa seed oil, which may be 
due to the colorimetric nature of the test. The seed oil of N. sativa is dark 
brown in color that turns dark purple after MTT testing. Dense color 
changes can result in higher absorbance values, which affect the OD 
value leading to higher values in the treatment group when compared 
with the controls. In addition to the color factor, volatile oil turbidity 
may also affect the OD value.
CONCLUSION
N. sativa seed extract can reduce the viability of C. glabrata, which was 
found to decrease with increased concentrations of the extract in the 
current study.
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